Evidence map›Paper›PMID 35328479›Full record

ReviewInternational journal of molecular sciences2022

Discovery and Biotechnological Exploitation of Glycoside-Phosphorylases.

Ao Li, Mounir Benkoulouche, Simon Ladeveze, Julien Durand, Gianluca Cioci, Elisabeth Laville, Gabrielle Potocki-Veronese

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Comparative Analysis ofApplied and environmental microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ao LiToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.ORCID 0000-0002-8909-5012
Mounir BenkouloucheToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.ORCID 0000-0001-9923-1498
Simon LadevezeToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.
Julien DurandToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.
Gianluca CiociToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.
Elisabeth LavilleToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.
Gabrielle Potocki-VeroneseToulouse Biotechnology Institute (TBI), Centre National de la Recherche Scientifique (CNRS) Toulouse Biotechnology Institute (TBI), French National Research Institute for Agriculture, Food and Environment (INRAE), Institut National des Sciences Appliquées (INSA), Université de Toulouse, 31000 Toulouse, France.ORCID 0000-0003-4232-230X
Centre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-16-CE20-0006, OligometEuropean Union's Horizon 2020 framework programme FNR-2020-SEP-210639118, RadicalZEuropean Union's Horizon 2020 framework programme LEIT-BIO-2015-685474, Metafluidics
6 · The paper itself

Abstract

Among carbohydrate active enzymes, glycoside phosphorylases (GPs) are valuable catalysts for white biotechnologies, due to their exquisite capacity to efficiently re-modulate oligo- and poly-saccharides, without the need for costly activated sugars as substrates. The reversibility of the phosphorolysis reaction, indeed, makes them attractive tools for glycodiversification. However, discovery of new GP functions is hindered by the difficulty in identifying them in sequence databases, and, rather, relies on extensive and tedious biochemical characterization studies. Nevertheless, recent advances in automated tools have led to major improvements in GP mining, activity predictions, and functional screening. Implementation of GPs into innovative in vitro and in cellulo bioproduction strategies has also made substantial advances. Herein, we propose to discuss the latest developments in the strategies employed to efficiently discover GPs and make the best use of their exceptional catalytic properties for glycoside bioproduction.

Indexed as

Cardiac GlycosidesGlycosidesBiotechnologyCatalysisGlycoside HydrolasesPhosphorylasesCardiac GlycosidesGlycoside HydrolasesGlycosidesPhosphorylasesbiotechnologycarbohydrate-active enzymesfunctional metagenomicsglycochemistryglycoside phosphorylasesglycosidesscreeningsequence similarity networks

Identifiers

PMID35328479
PMCPMC8950772
OpenAlexW4220902144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.